{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "Diastolic dysfunction",
      "Exercise testing",
      "Ivabradine",
      "Left ventricular filling pressure",
      "NT-proBNP"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "26687495",
  "DateCompleted": {
    "Year": "2017",
    "Month": "02",
    "Day": "23"
  },
  "DateRevised": {
    "Year": "2018",
    "Month": "12",
    "Day": "02"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2015",
        "Month": "12",
        "Day": "19"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1007/s00392-015-0950-0"
    ],
    "Journal": {
      "ISSN": "1861-0692",
      "JournalIssue": {
        "Volume": "105",
        "Issue": "6",
        "PubDate": {
          "Year": "2016",
          "Month": "Jun"
        }
      },
      "Title": "Clinical research in cardiology : official journal of the German Cardiac Society",
      "ISOAbbreviation": "Clin Res Cardiol"
    },
    "ArticleTitle": "\u03b2-Blockers and ivabradine differentially affect cardiopulmonary function and left ventricular filling index.",
    "Pagination": {
      "StartPage": "527",
      "EndPage": "534",
      "MedlinePgn": "527-34"
    },
    "Abstract": {
      "AbstractText": [
        "Patients with left ventricular (LV) diastolic dysfunction are characterized by exertional dyspnoea. Heart rate (HR) reduction by \u03b2-blockers can improve exercise tolerance by prolonging LV filling, but their negative inotropic and lusitropic properties can be detrimental in this disease. We tested the effects of administering ivabradine, a HR-lowering drug without impact on cardiac kinetics that may favorably affect diastolic function.",
        "Twenty-four patients with coronary artery disease (CAD) and normal LV ejection fraction on chronic \u03b2-blocker therapy were included. NT-proBNP serum levels were determined prior to and after cardiopulmonary exercise. \u03b2-Blockers were then replaced by ivabradine and patients were re-tested after 6 weeks. Patients were initially classified as having a low (E/e'\u00a0\u2264\u00a08; n\u00a0=\u00a011) or high (E/e'\u00a0>\u00a08; n\u00a0=\u00a013) LV filling index.",
        "E/e' significantly decreased during ivabradine therapy in patients with high E/e' (10.7\u00a0\u00b1\u00a02.9 vs. 8.9\u00a0\u00b1\u00a01.7; p\u00a0<\u00a00.01), whereas no difference occurred in patients with low E/e' (6.4\u00a0\u00b1\u00a00.7 vs. 6.5\u00a0\u00b1\u00a01.1; p\u00a0=\u00a0ns). With ivabradine, patients with high E/e' had an increased oxygen uptake at the anaerobic threshold (from 10.8\u00a0\u00b1\u00a01.4 to 11.8\u00a0\u00b1\u00a01.9\u00a0ml/min/kg; p\u00a0<\u00a00.05) and a steeper slope of the initial oxygen pulse curve (from 293\u00a0\u00b1\u00a0109 to 359\u00a0\u00b1\u00a0117\u00a0\u00b5l/beat/kg/W; p\u00a0<\u00a00.05). Moreover, patients with high E/e' had lower NT-proBNP serum levels at rest (169\u00a0\u00b1\u00a0207 vs. 126\u00a0\u00b1\u00a0146\u00a0pg/ml; p\u00a0<\u00a00.05) and after exercise (190\u00a0\u00b1\u00a0256 vs. 136\u00a0\u00b1\u00a0162\u00a0pg/ml; p\u00a0<\u00a00.05) during ivabradine therapy.",
        "In patients with CAD and elevated E/e', switching therapy from \u03b2-blockers to ivabradine may cause a reduction in LV filling pressures and an improved stroke volume response to exercise."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Cardiology, Kerckhoff Heart Center, Benekestr. 2-8, 61231, Bad Nauheim, Germany. fischer-rasokat@gmx.de."
          }
        ],
        "LastName": "Fischer-Rasokat",
        "ForeName": "Ulrich",
        "Initials": "U"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Cardiology, University Hospital of the Goethe University, Theodor-Stern-Kai 7, 60596, Frankfurt/Main, Germany."
          }
        ],
        "LastName": "Honold",
        "ForeName": "J\u00f6rg",
        "Initials": "J"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Cardiology, University Hospital of the Goethe University, Theodor-Stern-Kai 7, 60596, Frankfurt/Main, Germany."
          }
        ],
        "LastName": "Lochmann",
        "ForeName": "Denise",
        "Initials": "D"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Cardiology, Kerckhoff Heart Center, Benekestr. 2-8, 61231, Bad Nauheim, Germany."
          }
        ],
        "LastName": "Wolter",
        "ForeName": "Sebastian",
        "Initials": "S"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Cardiology, Kerckhoff Heart Center, Benekestr. 2-8, 61231, Bad Nauheim, Germany."
          }
        ],
        "LastName": "Liebetrau",
        "ForeName": "Christoph",
        "Initials": "C"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Cardiology, University Hospital of the Goethe University, Theodor-Stern-Kai 7, 60596, Frankfurt/Main, Germany."
          }
        ],
        "LastName": "Fichtlscherer",
        "ForeName": "Stephan",
        "Initials": "S"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Cardiology, Kerckhoff Heart Center, Benekestr. 2-8, 61231, Bad Nauheim, Germany."
          }
        ],
        "LastName": "M\u00f6llmann",
        "ForeName": "Helge",
        "Initials": "H"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Cardiology, University Hospital of the Goethe University, Theodor-Stern-Kai 7, 60596, Frankfurt/Main, Germany."
          }
        ],
        "LastName": "Spyridopoulos",
        "ForeName": "Ioakim",
        "Initials": "I"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Cardiology, Kerckhoff Heart Center, Benekestr. 2-8, 61231, Bad Nauheim, Germany."
          }
        ],
        "LastName": "Hamm",
        "ForeName": "Christian W",
        "Initials": "CW"
      }
    ],
    "PublicationTypeList": [
      "Clinical Trial",
      "Comparative Study",
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "Germany",
    "MedlineTA": "Clin Res Cardiol",
    "NlmUniqueID": "101264123",
    "ISSNLinking": "1861-0684"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Adrenergic beta-Antagonists"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Anti-Arrhythmia Agents"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Benzazepines"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Biomarkers"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Peptide Fragments"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "pro-brain natriuretic peptide (1-76)"
    },
    {
      "RegistryNumber": "114471-18-0",
      "NameOfSubstance": "Natriuretic Peptide, Brain"
    },
    {
      "RegistryNumber": "3H48L0LPZQ",
      "NameOfSubstance": "Ivabradine"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "adverse effects",
        "therapeutic use"
      ],
      "DescriptorName": "Adrenergic beta-Antagonists"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Aged"
    },
    {
      "QualifierName": [
        "adverse effects",
        "therapeutic use"
      ],
      "DescriptorName": "Anti-Arrhythmia Agents"
    },
    {
      "QualifierName": [
        "adverse effects",
        "therapeutic use"
      ],
      "DescriptorName": "Benzazepines"
    },
    {
      "QualifierName": [
        "blood"
      ],
      "DescriptorName": "Biomarkers"
    },
    {
      "QualifierName": [
        "diagnosis",
        "drug therapy",
        "physiopathology"
      ],
      "DescriptorName": "Coronary Artery Disease"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Drug Substitution"
    },
    {
      "QualifierName": [
        "physiopathology"
      ],
      "DescriptorName": "Dyspnea"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Exercise Test"
    },
    {
      "QualifierName": [
        "drug effects"
      ],
      "DescriptorName": "Exercise Tolerance"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [
        "drug effects"
      ],
      "DescriptorName": "Heart Rate"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Ivabradine"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Middle Aged"
    },
    {
      "QualifierName": [
        "blood"
      ],
      "DescriptorName": "Natriuretic Peptide, Brain"
    },
    {
      "QualifierName": [
        "blood"
      ],
      "DescriptorName": "Peptide Fragments"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Pilot Projects"
    },
    {
      "QualifierName": [
        "drug effects"
      ],
      "DescriptorName": "Stroke Volume"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Time Factors"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Treatment Outcome"
    },
    {
      "QualifierName": [
        "diagnosis",
        "drug therapy",
        "physiopathology"
      ],
      "DescriptorName": "Ventricular Dysfunction, Left"
    },
    {
      "QualifierName": [
        "drug effects"
      ],
      "DescriptorName": "Ventricular Function, Left"
    }
  ]
}